Skip to main content

August 2012

 

 

academics

 

Clinical research courses

Application for the Post of Pharmacist Grade II KERALA PUBLIC SERVICE COMMISSION- 4 Posts

The State of Kerala was formed on 1st November 1956 consequent on the Reorganisation of States. It comprises the former Travancore-Cochin State (except the present Kanyakumari District and Shencottah Taluk of the present Tamil Nadu) and the Malabar District and the Kasargod Taluk of South Kanara District of the then composite Madras State.

Archives of Jobs & Projects for B.Pharm, M.Pharm, B.Sc, M.Sc, MBBS, MD of Fresher or Experience of June 2012
OPTIMIZATION FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF ASPIRIN AND ATORVASTATIN

About Authors:
Kalpen N. Patel*, Maulika S. Patel, Divya Thakkar, Manan Patel, Kaushal Raval
Shree Krishna Institute of Pharmacy, Shankhalpur,
Bechraji, Mahesana, Gujarat, India.
*kalpenpharma@gmail.com

ABSTRACT
Sustained releases tablets have been used for reduced the dosing frequency and maintain the plasma drug concentration level within narrow therapeutic range. Aspirin used as antiplatelate agent and Atorvastatin is HMG-CoA reductase inhibitor which lowers the plasma concentration of cholesterol. Here in present study sustained release tablets of Aspirin and Atorvastatin prepared by using cellulose acetate phthalate (CAP) and microcrystalline cellulose (MCC) as a polymers. The sustain release tablet of Aspirin And Atorvastatin were prepared by wet granulation method and were substituted for film coating to mask the spotting from Atorvastatin and for protection from light. From the dissolution profile of F2B2 gives controlling the release up to 12 hrs with required value i.e. - 55.85 % for Aspirin and 54.78 % for Atorvastatin in 4 hrs respectively and 100.70 % for Aspirin and 100.60 % for Atorvastatin in 12 hrs respectively. The result of stability studies of batch F2B2 indicate that it is stable at 400C / 75 % ±0.5 % relative humidity as there was no significant differences observe for dissolution and average drug content data after two months.

A STUDY ON ANTI-DIARRHOEAL ACTIVITY OF FRUIT EXTRACTS OF CARICA PAPAYA (CARICACEAE) LINN. IN RATS

About Authors:
S. Mahboob Ahmad, T.S Gouda
V.L. College of pharmacy,
Raichur, Karnataka-58410
*syed.ahmad007@yahoo.com

Abstract:
The alcoholic and aqueous extracts of fruit of Carica papaya (Caricaceae)was investigated for anti-diarrhoealactivity in albino Wistar rats. The alcoholic and aqueous extracts was administered by the oral route at a concentration of 100, 200 and 400 mg/kg showed the significant dose dependent anti-diarrhoeal activity in Castor oil induced diarrhea and Magnesium sulphate induced diarrhea. Anti-diarrhoeal activity of the tested extracts was comparable with that of the standard drug Loperamide 3 mg/kg. The results lend support to the traditional use of C.  papaya in the treatment of diarrhoeal diseases.

Faculty Posts as Professors/Lecturers in Mangalayatan University - 7 posts

Mangalayatan University (MU) has been created under the "Mangalayatan University, Uttar Pradesh Act" and notified by the Government of Uttar Pradesh as Act No. 32 of 2006, by its Gazette No. 362/VII-V-1-1(Ka)-12/2006 dated October 30, 2006, with the right to confer degrees under section (2f) and 22(1) of the UGC Act.

Sr PVE/Pharmacovigilance Leader(PVL) - Empirica Triage Team invited in Novartis

Novartis (NYSE: NVS) is a world leader in the research and development of products to protect and improve health and well-being.

Torrent Pharmaceuticals invites for Regulatory Affairs Technical Assistant

Torrent Pharmaceuticals Limited, is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. Torrent Pharma’s competitive advantage as a manufacturer stems from its world-class manufacturing facilities.

Senior Research Fellow invited in ACTREC- Walk in Interview

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia.

THROMBOPHILIA AND VENOUS THROMBOEMBOLISM IN PREGNANCY: DETECTION AND MANAGEMENT PARADIGM

About Authors:
Ritesh Shah*, Gaurav Chandawat, Rahul Jadav, Bhoomi Arora
Institute Of Clinical Research (India),
Ahmedabad, Gujarat-380013, India
*ritesh_shah99@yahoo.com

ABSTRACT
Venous thromboembolism (VTE) complicates approximately 1 to 2 of 1,000 pregnancies, with pulmonary embolism (PE) being a leading cause of maternal mortality and deep vein thrombosis (DVT) an important cause of maternal morbidity. The main reason for the increased risk of thromboembolism in pregnancy is hypercoagulability, which has likely evolved to protect women from the bleeding challenges of miscarriage and childbirth. Women are at a 4- to 5-fold increased risk of thromboembolism during pregnancy and the postpartum period compared with when they are not pregnant. Eighty percent of the thromboembolic events in pregnancy are venous, with an incidence of 0.61 to 1.72 per 1000 pregnancies.Includes a history of thrombosis, inherited and acquired thrombophilia, maternal age greater than 35, certain medical conditions, and various complications of pregnancy and childbirth.

Despite the increased risk of VTE during pregnancy and the postpartum period, most women do not require anticoagulation. The intensity of the anticoagulation will depend on the indication and the monitoring will depend on the intensity. At the time of delivery, anticoagulation should be manipulated to reduce the risk of bleeding complications while minimizing the risk of thrombosis. There are no large trials of anticoagulants in pregnancy, and recommendations are based on case series, extrapolations from nonpregnant patients and the opinion of experts. Nonetheless, anticoagulants are believed to improve the outcome of pregnancy for women who have, or have had, VTE.

ANTI ULCER ACTIVITY OF METHANOLIC EXTRACT OF LEAVES OF BOSWELLIA OVALIFOLIOLATA BAL&HENRY

About Authors:
M.Dhanalakshmi*, B. Maddilety
Department of pharmacology, Krishna Teja Pharmacy College,
Chadhalawada Nagar, Renigunta Road, Tirupathi-517 507,
Andhra Pradesh, India.
*Lakshmi.dhana17@gmail.com

ABSTRACT:
Boswellia ovalifoliolata bal&henry is an endemic plant that has been suggested as useful in the treatment of various diseases (anti diabetic, anti inflammatory, antimicrobial , antifungal, antibacterial).In the present study, anti ulcer activity of MELBO was studied by pylorus ligated,aspirin induced gastric ulceration in albino rats. Anti ulcer activity was evaluated by pylorus ligation, aspirin induced ulcer method by using standard ranitidine (27mg/kg).The anti ulcer activity was assessed by determining the ulcer index, pH and acidity. MELBO (400mg/kg) produced a significant reduction in the ulcer index, PH and acidity when compared with ulcer control group and standard group. MELBO reduces ulcer, there by the present study indicates that boswellia ovalifoliolata bal&henry showed protective activity on gastric ulcer.

(adsbygoogle = window.adsbygoogle || []).push({});